Альгинатол®
Producer: Stada Arzneimittel ("STADA Artsnaymittel") Germany
Code of automatic telephone exchange: B02BC
Release form: Firm dosage forms. Suppositories rectal.
General characteristics. Structure:
One suppository contains alginate sodium — 0,25 g and a basis (витепсол) up to 1,28 g.
Description. Suppositories of light gray color with a creamy shade, a torpedo-shaped form. Emergence of a plaque on the surface of suppository is allowed.
Pharmacological properties:
Sodium alginate (active agent of the drug Alginatol®) — the natural polysaccharide received from brown algas. Drug renders haemo static (stops bleeding), antiinflammatory and reparative action. Reduces inflammation signs; normalizes a picture of peripheral blood (SOE, leukocytes and hemoglobin).
Indications to use:
Proctosigmoiditis, the chronic bleeding hemorrhoids, anal fissures at children (in an epithelization stage), the inflammatory phenomena in a rectum in the postoperative period.
Route of administration and doses:
Rektalno.
Suppository is exempted from planimetric packaging and entered into a rectum after a cleansing enema, or spontaneous bowel emptying.
To children from 6 months to 1 year — on 1 suppository a day;
from 1 year to 4 years — on 1 suppository 2 times a day;
to children 4 years — on 1 suppository 2-3 times a day are more senior.
Duration of a course of treatment — 7-14 days.
Side effects:
Allergic reactions are possible.
Contraindications:
Hypersensitivity to drug components.
Storage conditions:
In unavailable to children the place at a temperature not above 25 °C.
Issue conditions:
Without recipe
Packaging:
Альгинатол® suppositories 250 mg, rectal for children, on 5 pieces in a blister strip packaging. 2 blister strip packagings together with the instruction on a medical use place in a cardboard pack.